Exciting things are happening every day at VCU Massey Cancer Center. We’re saving lives and reducing suffering from cancer. We’re discovering new and better ways to prevent, diagnose and treat cancer. We’re offering opportunities for the community to join us in the progress against cancer.
Updates to outpatient care at Massey due to COVID-19
At VCU Massey Cancer Center we have implemented changes in our clinics to mitigate the coronavirus (COVID-19) situation and keep our patients and medical teams safe.
Cervical cancer is the most common cancer in women worldwide. Finding effective therapies requires clinical trials, which can offer new options when other treatments have failed.
Leslie Randall, M.D., director of gynecologic oncology and a researcher at VCU Massey Cancer Center, discusses cervical cancer treatment, advances and current clinical trials underway at VCU Massey Cancer Center.
VCU Massey Cancer Center and Riverside Health System collaborate to expand access to cancer clinical trials throughout coastal Virginia
Cancer patients living in coastal Virginia have greater access to cutting-edge clinical trials now that Riverside Health System has joined Virginia Commonwealth University Massey Cancer Center’s Clinical Research Affiliate Network. This collaboration will bring National Cancer Institute (NCI)-sponsored clinical trials testing promising new cancer treatments to seven Riverside locations, including Peninsula Cancer Institute locations in Newport News, Williamsburg and Gloucester; Cancer Specialists of Tidewater locations in Virginia Beach, Chesapeake and Suffolk; and Riverside Shore Cancer Center in Onancock.
Massey researcher finds total deaths recorded during the pandemic far exceed those attributed to COVID-19
For every two deaths attributed to COVID-19 in the U.S., a third American dies as a result of the pandemic, according to study findings from Steven Woolf, M.D., M.P.H., member of the Cancer Prevention and Control research program at VCU Massey Cancer Center. The study, published in the Journal of the American Medical Association, shows that deaths between March 1 and August 1 increased 20% compared to previous years — maybe not surprising in a pandemic. But deaths attributed to COVID-19 only accounted for 67% of those deaths.
Social media policies can curb HPV vaccine misinformation and improve public health communications, but concerns remain
A new study led by VCU Massey Cancer Center researcher Jeanine Guidry, Ph.D., a member of the Cancer Prevention and Control research program, compared how HPV vaccination was portrayed on Pinterest before and after the social media platform began moderating vaccine-related content. Findings may help public health officials utilize social media to tackle potentially harmful rhetoric and disseminate trustworthy health information.
Massey director identifies genetic factor that could explain high rate of COVID-19 among African Americans
VCU Massey Cancer Center Director Robert Winn, M.D., recently collaborated on research that identified a genetic factor that could partly account for the high prevalence of COVID-19 in African Americans. The study, published in the Journal of Racial and Ethnic Health Disparities, could have clinical implications for the use of existing blood pressure and heart failure drugs to manage severe symptoms of the novel coronavirus.